ITEOS THERAPEUTICS, INC.

Transcripts iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
10.8 ^USD	+1.89%		+2.27%	-1.37%

Mar. 13	Top Premarket Decliners	MT
Mar. 12	JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : ITeos Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:00 PM	Jan. 10
Transcript : ITeos Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 08:15 AM	23-01-10
Transcript : ITeos Therapeutics, Inc. Presents at Citi’s 2022 Virtual Immuno-Oncology Summit, Feb-17-2022 01:30 PM	22-02-17
Transcript : iTeos Therapeutics, Inc., Q3 2021 Earnings Call, Nov 10, 2021	21-11-10
Transcript : ITeos Therapeutics, Inc., Q2 2021 Earnings Call, Aug 12, 2021	21-08-12
Transcript : iTeos Therapeutics, Inc. - Special Call	21-06-14
Transcript : iTeos Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 06:10 AM	21-01-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer